Medtronic’s TYRX Absorbable Antibacterial Envelope was awarded the second place Best in Show award inSurgical Products‘ annual Excellence in Surgical Products Awards. To learn more about the product,Surgical Products connected with the experts at Medtronic.
Why do you think readers were interested in hearing more about this product?
I believe that readers were interested in hearing more about the TYRX™ Absorbable Antibacterial Envelope because it meets such an important unmet patient need, the need for infection prevention during cardiac device procedures. The TYRX Absorbable Antibacterial Envelope also helps stabilize the cardiac device implant after implantation, another important product feature. And, an additional key feature of the product is that it is fully absorbable after about nine weeks. By being fully absorbable, there is no foreign body nidus for a potential infection, and there is no change necessary in surgical technique during change-out, upgrade or revision procedures. This is extremely important since most patients with cardiac devices are going to have multiple change-outs of their device over their lifetime.
How does this product benefit the surgical team and aid in better outcomes for patients?
The TYRX™ Absorbable Antibacterial Envelope benefits the surgical team and aids in better patient outcomes because it helps prevent Surgical Site Infections (SSIs) after device procedures. Having a patient acquire a SSI is traumatic to the patient due to having to be re-admitted to the hospital for systemic antibiotic treatment for at least two weeks. Additionally, patients who get SSIs have a significantly increased risk of mortality, with clinical study data showing that about 50 percent of patients die within three years after having a CIED Infection. Further, by preventing infections and thereby improving patient outcomes, facilities will spend less time and money treating these infections, which benefits not only the facility and its staff, but it also benefits the healthcare system as a whole. Recently, Medtronic Infection Control launched the TYRX™ Neuro Absorbable Antibacterial Envelope into the neurological market for use with Implantable Neurostimulators (INSs) for deep brain stimulators, sacral nerve stimulators, spinal cord stimulators and vagus nerve stimulators. By gaining these neuro clearances, the TYRX Neuro Absorbable Antibacterial Envelope will offer its stabilization and infection prevention capabilities to help address the unmet neuro patient need of helping prevent SSIs.
What technical innovations does this product encapsulate and apply to the OR?
The technical innovation that the TYRX Absorbable Antibacterial Envelopes encapsulate and apply to the Operating Room is the product’s capability to provide device stabilization and infection prevention. By providing these product capabilities, there are better patient outcomes and less patient morbidity and mortality. Additionally, by preventing these infections, the facility financial expenditure to treat these infections will be less which benefits the facility and the entire healthcare system.
This award was featured in the November/ December 2015 issue of Surgical Products. To see the complete issue, click HERE.
